A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

R, Kerwin; B, Millet; E, Herman; CM, Banki; H, Lublin; M, Pans; L, Hanssens; G, L'Italien; RD, McQuade; JN, Beuzen

doi:10.1016/j.eurpsy.2007.03.002

Public

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

Shared by NobleBlocks on Jun 7, 2007 • 12:00 AM UTC

Authors:

Kerwin R

Millet B

Herman E

Abstract

<h4>Background</h4>Naturalistic effectiveness trials of atypical antipsychotics are needed to provide broader information on efficacy, safety, and tolerability in patients with schizophrenia treated in a community practice setting.<h4>Method</h4>In this 26-week, open-label, multicentre study, patien...

Discussions